CIDRAP newsletters options
A study yesterday found that US patients hospitalized with COVID-19 are more likely to be male, younger, and have fewer comorbidities and lower medication use than hospitalized flu patients.
Also, the FDA posts its COVID-19 vaccine standards, ending a stalemate.
The US ranked 9th of 19 overall but scored high on income, food, and shelter aid.
Lopinavir-ritonavir didn't shorten hospital stay or lower the risk of mechanical ventilation or death.
A diagnostic stewardship program at a large Los Angeles hospital was associated with significantly reduced inpatient urine culture orders and rates of hospital-acquired catheter-associated urinary tract infections (CAUTIs), researchers reported today in Clinical Infectious Diseases.
A study yesterday found an 82.3% rate of neurologic symptoms among 509 hospitalized COVID-19 patients, with some symptoms associated with increased death rates.
Also, the CDC updates its COVID-19 guidance to include more on airborne spread.
COVID-19 has disrupted services for mental health, neurologic conditions, and substance abuse.
The patients didn't have severe symptoms such as respiratory failure.
CARB-X announced today that it is awarding up to $2.5 million to GangaGen Biotechnologies of Bangalore, India, to develop novel antibacterial proteins to treat hospital-acquired and ventilator-associated pneumonia caused by Klebsiella pneumoniae.
A JAMA study today analyzing trends in internet searches found increased queries for anxiety, panic attack, and insomnia during the New York statewide lockdown in March, with searches for depression and suicide remaining at expected levels.
In breaking news, President Trump is headed for Walter Reed Hospital.
Providers can do more to encourage vaccines, the CDC says.
Also, CEPI launches a lab network to do head-to-head evaluations of vaccine candidates.
"These are not trivial declines: They are large, clinically important declines."
Initial results from the FMT (fecal microbiota transplantation) National Registry indicate that FMT is highly effective for treating Clostridioides difficile infection (CDI), with a good safety profile, US researchers reported yesterday in Gastroenterology.
People with Parkinson's disease (PD) have a 30% higher risk of COVID-19 death, according to a University of Iowa news release yesterday and a recent study in Movement Disorders.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The US adds 42,812 new cases to the global pandemic total.
Lessons learned from the outbreak may apply to other congregate settings.
